Document ID: chunk:federal_register_of_legislation:F2025L00212:clause:1_2395
Version: federal_register_of_legislation:F2025L00212
Segment Type: clause
Provision Reference: sch 1 cl 2395
Character Range: 1145986–1146797

2395                                      GLYCERYL MONO AND DICAPRYLOCAPRATE                         E         Only permitted for use in medicines limited to oral routes of administration, or when in combination with other permitted ingredients as a fragrance proprietary excipient formulation.
                                                                                                               The maximum recommended oral daily dose of the medicine must not provide more than 8 mg of glyceryl mono and dicaprylocaprate.
                                                                                                               The total concentration of fragrance proprietary excipient formulations containing glyceryl mono and dicaprylocaprate must not be more than 1% of the total medicine.